Report Detail
Global HPV Vaccines Market Insights, Forecast to 2025
- RnM3488061 |
- 04 June, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Human papilloma virus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus. Available vaccines protect against either two, four, or nine types of HPV. All vaccines protect against at least HPV type 16 and 18 that cause the greatest risk of cervical cancer. It is estimated that they may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer, and possibly some mouth cancer. They additionally prevent some genital warts with the vaccines against 4 and 9 HPV types providing greater protection.
HPV vaccine is an inactivated (not live) vaccine which protects against four major types of HPV. These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Human papillomaviruses (HPVs) are a group of more than 200 related viruses. More than 40 HPV types can be easily spread through direct sexual contact, from the skin and mucous membranes of infected people to the skin and mucous membranes of their partners. They can be spread by vaginal, anal, and oral sex (1). Other HPV types are responsible for non-genital warts, which are not sexually transmitted. The segment of Female HPV vaccine market witnessed growth at a noteworthy rate over the past few years and is expected to grow in the forecast period on the back of rising awareness regarding HPV related fatal diseases, rising healthcare expenditures along with rising disposable incomes. North America and Europe accounts for the maximum market share of the global HPV vaccines market and is expected to grow at highest CAGR during the forecast period.
The global HPV Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the HPV Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of HPV Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of HPV Vaccines in these regions.
This research report categorizes the global HPV Vaccines market by top players/brands, region, type and end user. This report also studies the global HPV Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Astellas Pharma
CSL
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Pfizer
Sanofi Pasteur
Serum Institute
Market size by Product
Adolescents
Adults
Market size by End User
Male
Female
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global HPV Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of HPV Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global HPV Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of HPV Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of HPV Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of HPV Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 HPV Vaccines Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global HPV Vaccines Market Size Growth Rate by Product
- 1.4.2 Adolescents
- 1.4.3 Adults
- 1.5 Market by End User
- 1.5.1 Global HPV Vaccines Market Size Growth Rate by End User
- 1.5.2 Male
- 1.5.3 Female
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global HPV Vaccines Market Size
- 2.1.1 Global HPV Vaccines Revenue 2014-2025
- 2.1.2 Global HPV Vaccines Sales 2014-2025
- 2.2 HPV Vaccines Growth Rate by Regions
- 2.2.1 Global HPV Vaccines Sales by Regions
- 2.2.2 Global HPV Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 HPV Vaccines Sales by Manufacturers
- 3.1.1 HPV Vaccines Sales by Manufacturers
- 3.1.2 HPV Vaccines Sales Market Share by Manufacturers
- 3.1.3 Global HPV Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.2 HPV Vaccines Revenue by Manufacturers
- 3.2.1 HPV Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 HPV Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.3 HPV Vaccines Price by Manufacturers
- 3.4 HPV Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 HPV Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers HPV Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into HPV Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global HPV Vaccines Sales by Product
- 4.2 Global HPV Vaccines Revenue by Product
- 4.3 HPV Vaccines Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global HPV Vaccines Breakdown Data by End User
6 North America
- 6.1 North America HPV Vaccines by Countries
- 6.1.1 North America HPV Vaccines Sales by Countries
- 6.1.2 North America HPV Vaccines Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America HPV Vaccines by Product
- 6.3 North America HPV Vaccines by End User
7 Europe
- 7.1 Europe HPV Vaccines by Countries
- 7.1.1 Europe HPV Vaccines Sales by Countries
- 7.1.2 Europe HPV Vaccines Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe HPV Vaccines by Product
- 7.3 Europe HPV Vaccines by End User
8 Asia Pacific
- 8.1 Asia Pacific HPV Vaccines by Countries
- 8.1.1 Asia Pacific HPV Vaccines Sales by Countries
- 8.1.2 Asia Pacific HPV Vaccines Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific HPV Vaccines by Product
- 8.3 Asia Pacific HPV Vaccines by End User
9 Central & South America
- 9.1 Central & South America HPV Vaccines by Countries
- 9.1.1 Central & South America HPV Vaccines Sales by Countries
- 9.1.2 Central & South America HPV Vaccines Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America HPV Vaccines by Product
- 9.3 Central & South America HPV Vaccines by End User
10 Middle East and Africa
- 10.1 Middle East and Africa HPV Vaccines by Countries
- 10.1.1 Middle East and Africa HPV Vaccines Sales by Countries
- 10.1.2 Middle East and Africa HPV Vaccines Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa HPV Vaccines by Product
- 10.3 Middle East and Africa HPV Vaccines by End User
11 Company Profiles
- 11.1 Astellas Pharma
- 11.1.1 Astellas Pharma Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Astellas Pharma HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Astellas Pharma HPV Vaccines Products Offered
- 11.1.5 Astellas Pharma Recent Development
- 11.2 CSL
- 11.2.1 CSL Company Details
- 11.2.2 Company Business Overview
- 11.2.3 CSL HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 CSL HPV Vaccines Products Offered
- 11.2.5 CSL Recent Development
- 11.3 Emergent BioSolutions
- 11.3.1 Emergent BioSolutions Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Emergent BioSolutions HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Emergent BioSolutions HPV Vaccines Products Offered
- 11.3.5 Emergent BioSolutions Recent Development
- 11.4 GlaxoSmithKline
- 11.4.1 GlaxoSmithKline Company Details
- 11.4.2 Company Business Overview
- 11.4.3 GlaxoSmithKline HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 GlaxoSmithKline HPV Vaccines Products Offered
- 11.4.5 GlaxoSmithKline Recent Development
- 11.5 Johnson & Johnson
- 11.5.1 Johnson & Johnson Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Johnson & Johnson HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Johnson & Johnson HPV Vaccines Products Offered
- 11.5.5 Johnson & Johnson Recent Development
- 11.6 MedImmune
- 11.6.1 MedImmune Company Details
- 11.6.2 Company Business Overview
- 11.6.3 MedImmune HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 MedImmune HPV Vaccines Products Offered
- 11.6.5 MedImmune Recent Development
- 11.7 Merck
- 11.7.1 Merck Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Merck HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Merck HPV Vaccines Products Offered
- 11.7.5 Merck Recent Development
- 11.8 Pfizer
- 11.8.1 Pfizer Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Pfizer HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Pfizer HPV Vaccines Products Offered
- 11.8.5 Pfizer Recent Development
- 11.9 Sanofi Pasteur
- 11.9.1 Sanofi Pasteur Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Sanofi Pasteur HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Sanofi Pasteur HPV Vaccines Products Offered
- 11.9.5 Sanofi Pasteur Recent Development
- 11.10 Serum Institute
- 11.10.1 Serum Institute Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Serum Institute HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Serum Institute HPV Vaccines Products Offered
- 11.10.5 Serum Institute Recent Development
12 Future Forecast
- 12.1 HPV Vaccines Market Forecast by Regions
- 12.1.1 Global HPV Vaccines Sales Forecast by Regions 2019-2025
- 12.1.2 Global HPV Vaccines Revenue Forecast by Regions 2019-2025
- 12.2 HPV Vaccines Market Forecast by Product
- 12.2.1 Global HPV Vaccines Sales Forecast by Product 2019-2025
- 12.2.2 Global HPV Vaccines Revenue Forecast by Product 2019-2025
- 12.3 HPV Vaccines Market Forecast by End User
- 12.4 North America HPV Vaccines Forecast
- 12.5 Europe HPV Vaccines Forecast
- 12.6 Asia Pacific HPV Vaccines Forecast
- 12.7 Central & South America HPV Vaccines Forecast
- 12.8 Middle East and Africa HPV Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 HPV Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on HPV Vaccines . Industry analysis & Market Report on HPV Vaccines is a syndicated market report, published as Global HPV Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of HPV Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
